Quercetin in elimination of tumor initiating stem-like and mesenchymal transformation property in head and neck cancer

Head and Neck

Volumn 35, Issue 3, 2013, Pages 413-419

  Chang, Wen Wei ^a   Hu, Fang Wei ^a,b   Yu, Cheng Chia ^a,b   Wang, Hsiu Huan ^a   Feng, Hsiang Pu ^a   Lan, Chih ^a   Tsai, Lo Lin ^a,b   Chang, Yu Chao ^a,b  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

epithelial mesenchymal transition; head and neck cancer; metastasis; quercetin; tumor initiating cells

Indexed keywords

ALDH1 PROTEIN; NERVE CELL ADHESION MOLECULE; PROTEIN; QUERCETIN; TRANSCRIPTION FACTOR TWIST; UNCLASSIFIED DRUG; VIMENTIN;

ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FLOW CYTOMETRY; HEAD AND NECK CANCER; HEAD AND NECK CANCER TUMOR INITIATING CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; ISOENZYMES; NEOPLASTIC STEM CELLS; QUERCETIN; RETINAL DEHYDROGENASE;

EID: 84874108284     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.22982     Document Type: Article

References (33)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96.
2. Chen YJ, Chang JT, Liao CT, et al. Head and neck cancer in the betel quid chewing area: recent advances in molecular carcinogenesis. Cancer Sci 2008; 99: 1507-1514.
3. Rosen JM, Jordan CT,. The increasing complexity of the cancer stem cell paradigm. Science 2009; 324: 1670-1673.
4. Costea DE, Tsinkalovsky O, Vintermyr OK, Johannessen AC, Mackenzie IC,. Cancer stem cells-new and potentially important targets for the therapy of oral squamous cell carcinoma. Oral Dis 2006; 12: 443-454.
5. Prince ME, Sivanandan R, Kaczorowski A, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A 2007; 104: 973-978.
6. Wu MJ, Jan CI, Tsay YG, et al. Elimination of head and neck cancer initiating cells through targeting glucose regulated protein78 signaling. Mol Cancer 2010; 9: 283.
7. Yu CC, Chen YW, Chiou GY, et al. MicroRNA let-7a represses chemoresistance and tumourigenicity in head and neck cancer via stem-like properties ablation. Oral Oncol 2011; 47: 202-210.
8. Lo WL, Yu CC, Chiou GY, et al. MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells. J Pathol 2011; 223: 482-495.
9. Clay MR, Tabor M, Owen JH, et al. Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase. Head Neck 2010; 32: 1195-1201.
10. Acloque H, Adams MS, Fishwick K, Bronner-Fraser M, Nieto MA,. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest 2009; 119: 1438-1449.
11. Polyak K, Weinberg RA,. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 2009; 9: 265-273.
12. Mani SA, Guo W, Liao MJ, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704-715.
13. Kong D, Banerjee S, Ahmad A, et al. Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells. PLoS One 2010; 5: e12445.
14. Murakami A, Ashida H, Terao J,. Multitargeted cancer prevention by quercetin. Cancer Lett 2008; 269: 315-325.
15. Sun ZJ, Chen G, Hu X, et al. Activation of PI3K/Akt/IKK-alpha/NF-kappaB signaling pathway is required for the apoptosis-evasion in human salivary adenoid cystic carcinoma: its inhibition by quercetin. Apoptosis 2010; 15: 850-863.
16. Lin CW, Hou WC, Shen SC, et al. Quercetin inhibition of tumor invasion via suppressing PKC delta/ERK/AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cells. Carcinogenesis 2008; 29: 1807-1815.
17. Tang SN, Singh C, Nall D, Meeker D, Shankar S, Srivastava RK,. The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition. J Mol Signal 2010; 5: 14.
18. Chang YC, Tsai CH, Tai KW, Yang SH, Chou MY, Lii CK,. Elevated vimentin expression in buccal mucosal fibroblasts by arecoline in vitro as a possible pathogenesis for oral submucous fibrosis. Oral Oncol 2002; 38: 425-430.
19. Yang MH, Wu MZ, Chiou SH, et al. Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol 2008; 10: 295-305.
20. Chen C, Wei Y, Hummel M, et al. Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma. PLoS One 2011; 6: e16466.
21. Gupta PB, Chaffer CL, Weinberg RA,. Cancer stem cells: mirage or reality? Nat Med 2009; 15: 1010-1012.
22. Dean M, Fojo T, Bates S,. Tumour stem cells and drug resistance. Nat Rev Cancer 2005; 5: 275-284.
23. Thiery JP,. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2: 442-454.
24. Ben-Porath I, Thomson MW, Carey VJ, et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nature genetics 2008; 40: 499-507.
25. Gupta PB, Onder TT, Jiang G, et al. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 2009; 138: 645-659.
26. Yang HM, Do HJ, Oh JH, et al. Characterization of putative cis-regulatory elements that control the transcriptional activity of the human Oct4 promoter. J Cell Biochem 2005; 96: 821-830.
27. Yuan H, Gong A, Young CY,. Involvement of transcription factor Sp1 in quercetin-mediated inhibitory effect on the androgen receptor in human prostate cancer cells. Carcinogenesis 2005; 26: 793-801.
28. Granado-Serrano AB, Martín MA, Bravo L, Goya L, Ramos S,. Quercetin modulates NF-kappa B and AP-1/JNK pathways to induce cell death in human hepatoma cells. Nutr Cancer 2010; 62: 390-401.
29. Jordan CT, Guzman ML, Noble M,. Cancer stem cells. N Engl J Med 2006; 355: 1253-1261.
30. Dong TT, Zhou HM, Wang LL, Feng B, Lv B, Zheng MH,. Salinomycin selectively targets 'CD133+' cell subpopulations and decreases malignant traits in colorectal cancer lines. Ann Surg Oncol 2011; 18: 1797-1804.
31. Tsai CH, Yang SF, Chen YJ, Chou MY, Chang YC,. The upregulation of insulin-like growth factor-1 in oral submucous fibrosis. Oral Oncol 2005; 41: 940-946.
32. Li Y, VandenBoom TG 2nd, Kong D, et al. Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Res 2009; 69: 6704-6712.
33. Prasad CP, Rath G, Mathur S, Bhatnagar D, Ralhan R,. Potent growth suppressive activity of curcumin in human breast cancer cells: modulation of Wnt/beta-catenin signaling. Chem Biol Interact 2009; 181: 263-271.